Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
US Department of Justice
US Army
Colorcon
Farmers Insurance
Medtronic
QuintilesIMS
Johnson and Johnson
Cerilliant
Moodys

Generated: January 24, 2018

DrugPatentWatch Database Preview

DITROPAN Drug Profile

« Back to Dashboard

When do Ditropan patents expire, and when can generic versions of Ditropan launch?

Ditropan is a drug marketed by Ortho Mcneil Janssen and Janssen Pharms and is included in three NDAs.

The generic ingredient in DITROPAN is oxybutynin chloride. There are sixteen drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the oxybutynin chloride profile page.

US Patents and Regulatory Information for DITROPAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil Janssen DITROPAN oxybutynin chloride SYRUP;ORAL 018211-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Janssen Pharms DITROPAN XL oxybutynin chloride TABLET, EXTENDED RELEASE;ORAL 020897-002 Dec 16, 1998 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Janssen Pharms DITROPAN oxybutynin chloride TABLET;ORAL 017577-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Janssen Pharms DITROPAN XL oxybutynin chloride TABLET, EXTENDED RELEASE;ORAL 020897-001 Dec 16, 1998 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Janssen Pharms DITROPAN XL oxybutynin chloride TABLET, EXTENDED RELEASE;ORAL 020897-003 Jun 22, 1999 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
McKinsey
Moodys
Dow
US Department of Justice
Fish and Richardson
US Army
Teva
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot